![Deepak Srivastava](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Deepak Srivastava
Fondateur chez
TENAYA THERAPEUTICS, INC.
Fortune : 340 717 $ au 30/09/2026
Profil
Deepak Srivastava is the founder of Tenaya Therapeutics, Inc., founded in 2016, where the title held is Independent Director.
Current jobs include Director at Roddenberry Center For Stem Cell Biology & Medicine, Professor at The University of California, San Francisco, Member at American Academy of Arts & Sciences, President at The J.
David Gladstone Institutes since 2018, Member at National Academy of Medicine, and Professor at Gladstone Institute of Cardiovascular Disease.
Former job includes President at The International Society for Stem Cell Research.
Education history includes undergraduate degree from William Marsh Rice University and doctorate from The University of Texas at Austin.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 28/05/2026 | 564 101 ( 0,25 % ) | 340 717 $ | 30/09/2026 |
Postes actifs de Deepak Srivastava
| Sociétés | Poste | Début |
|---|---|---|
| TENAYA THERAPEUTICS, INC. | Fondateur | 01/10/2016 |
The J. David Gladstone Institutes
 The J. David Gladstone Institutes Miscellaneous Commercial ServicesCommercial Services Engages in conducting research in biotechnology | President | 01/01/2018 |
The University of California, San Francisco
 The University of California, San Francisco Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
American Academy of Arts & Sciences
 American Academy of Arts & Sciences Miscellaneous Commercial ServicesCommercial Services Operates as organization which honours excellence and convenes leaders | Corporate Officer/Principal | - |
National Academy of Medicine | Corporate Officer/Principal | - |
Anciens postes connus de Deepak Srivastava
| Sociétés | Poste | Fin |
|---|---|---|
The International Society for Stem Cell Research
 The International Society for Stem Cell Research Miscellaneous Commercial ServicesCommercial Services Operates as a nonprofit organization that promotes stem cell research, education, ethical standards and clinical translation | President | - |
Formation de Deepak Srivastava
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
73
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Rice University
 Rice University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Texas at Austin
 The University of Texas at Austin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of California, San Francisco
The University of California, San Francisco Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
American Academy of Arts & Sciences
American Academy of Arts & Sciences Miscellaneous Commercial ServicesCommercial Services Operates as organization which honours excellence and convenes leaders | Commercial Services |
The J. David Gladstone Institutes
The J. David Gladstone Institutes Miscellaneous Commercial ServicesCommercial Services Engages in conducting research in biotechnology | Commercial Services |
The International Society for Stem Cell Research
The International Society for Stem Cell Research Miscellaneous Commercial ServicesCommercial Services Operates as a nonprofit organization that promotes stem cell research, education, ethical standards and clinical translation | Commercial Services |
National Academy of Medicine | |
Tenaya Therapeutics, Inc.
 Tenaya Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for heart failure | Health Technology |
